HuGE Literature Finder
Records
1
-
13
| IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroups. Neuro-oncology 2021 Oct . Rudà Roberta, Bruno Francesco, Ius Tamara, Silvani Antonio, Minniti Giuseppe, Pace Andrea, Lombardi Giuseppe, Bertero Luca, Pizzolitto Stefano, Pollo Bianca, Conti Nibali Marco, Pellerino Alessia, Migliore Enrica, Skrap Miran, Bello Lorenzo, Soffietti Riccar |
| Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma Cohorts. Journal of neuropathology and experimental neurology 2020 Jul . Galbraith Kristyn, Kumar Ashwani, Abdullah Kalil G, Walker Jamie M, Adams Steven H, Prior Timothy, Dimentberg Ryan, Henderson Fraser C, Mirchia Kanish, Sathe Adwait Amod, Viapiano Mariano S, Chin Lawrence S, Corona Robert J, Hatanpaa Kimmo J, Snuderl Matija, Xing Chao, Brem Steven, Richardson Timothy |
| Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics. Neuropathology and applied neurobiology 2020 Jul . Petersen Jeanette K, Boldt Henning B, Sørensen Mia D, Blach Steffi, Dahlrot Rikke H, Hansen Steinbjørn, Burton Mark, Thomassen Mads, Kruse Torben, Poulsen Frantz R, Andreasen Lotte, Hager Henrik, Ulhøi Benedicte P, Lukacova Slavka, Reifenberger Guido, Kristensen Bjarne |
| Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. BMC cancer 2019 Oct 19 (1): 968. Brito Cheila, Azevedo Ana, Esteves Susana, Marques Ana Rita, Martins Carmo, Costa Ilda, Mafra Manuela, Bravo Marques José M, Roque Lúcia, Pojo Mar |
| Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
| Common genetic variations in cell cycle and DNA repair pathways associated with pediatric brain tumor susceptibility. Oncotarget 2016 Sep 7 (39): 63640-63650. Adel Fahmideh Maral, Lavebratt Catharina, Schüz Joachim, Röösli Martin, Tynes Tore, Grotzer Michael A, Johansen Christoffer, Kuehni Claudia E, Lannering Birgitta, Prochazka Michaela, Schmidt Lisbeth S, Feychting Mar |
| Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
| Prognostic value of epidermal growth factor receptor amplification and EGFRvIII in glioblastoma: meta-analysis. Acta neurologica Scandinavica 2015 Apr . Chen J-R, Xu H-Z, Yao Y, Qin Z |
| Association of polymorphisms in FLT3, EGFR, ALOX5, and NEIL3 with glioblastoma in the Han Chinese population. Medical oncology (Northwood, London, England) 2013 Dec 30 (4): 718. Jin Tian-Bo, Li Xiao-Lan, Yang Hua, Jiri Mutu, Shi Xu-Gang, Yuan Dong-Ya, Kang Long-Li, Li Shan- |
| IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Oct 15 (19): 6002-7. Nobusawa Sumihito, Watanabe Takuya, Kleihues Paul, Ohgaki Hiro |
| Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Jul 14 (7): 1774-83. Wiencke John K, Aldape Kenneth, McMillan Alex, Wiemels Joe, Moghadassi Michelle, Miike Rei, Kelsey Karl T, Patoka Joe, Long Jeff, Wrensch Margar |
| PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Journal of the National Cancer Institute 2001 Aug 93 (16): 1246-56. Smith J S, Tachibana I, Passe S M, Huntley B K, Borell T J, Iturria N, O'Fallon J R, Schaefer P L, Scheithauer B W, James C D, Buckner J C, Jenkins R |
| Association of EGFR c.2073A>T polymorphism with decreased risk of diffusely infiltrating astrocytoma in a Brazilian case-control study. The International journal of biological markers 0 23 (3): 140-6. Barbosa K C, Oba-Shinjo S M, Uno M, Carvalho P O, Rosemberg S, Aguiar P H P, Carlotti C G, Malheiros S M F, Toledo S, Lotufo P, Marie S K |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 09, 2022
- Content source: